Immediate Impact
3 by Nobel laureates 35 from Science/Nature 60 standout
Citing Papers
Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
2023 Standout
Works of David G. Menter being referenced
Validation of HER2 Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer
2019
HER2 amplification as a negative predictive biomarker for anti-epidermal growth factor receptor antibody therapy in metastatic colorectal cancer.
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| David G. Menter | 2549 | 1405 | 2026 | 134 | 5.7k | |
| John G. Kuhn | 3365 | 1389 | 3733 | 188 | 8.6k | |
| Joji Kitayama | 2635 | 1349 | 2857 | 194 | 7.3k | |
| Janet A. Houghton | 2942 | 893 | 4297 | 144 | 6.4k | |
| Nelson H. Tsuno | 1508 | 771 | 1693 | 166 | 4.7k | |
| Steffen Hauptmann | 1373 | 1014 | 2090 | 109 | 4.8k | |
| Massimo Broggini | 3086 | 1379 | 4729 | 234 | 7.4k | |
| Eugenio Erba | 1243 | 787 | 2118 | 138 | 4.6k | |
| William P. Tong | 2030 | 636 | 3543 | 109 | 6.5k | |
| Tetsuji Sawada | 1439 | 831 | 1792 | 164 | 5.0k | |
| Ying Yang | 1638 | 1231 | 2104 | 132 | 5.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...